Maddy summaryThis bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.
Sponsored bills
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
Maddy summaryHR 564 redirects unspent funds from the American Rescue Plan Act of 2021 (ARP) to reduce the federal deficit. It requires all unobligated ARP funds - money allocated but not yet spent - to be sent to the Treasury's general fund upon the bill's enactment. This action directly affects federal budget accounting by canceling unused appropriations rather than creating new programs or aiding specific groups. The bill does not alter existing laws or services but focuses solely on reallocating existing, unspent federal funds. It is a procedural budget measure with no direct impact on taxpayers or beneficiaries of the ARP.
Maddy summaryThe Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship granting organizations providing education scholarships. Individuals can claim a credit up to $5,000 or 10% of their income, while corporations can claim up to 5% of taxable income. The scholarships are available to students from households with income up to 300% of the area median income, and can be used for private school tuition, tutoring, and other educational expenses at elementary and secondary schools. The bill includes strict requirements for scholarship organizations to verify income, conduct audits, and prevent misuse of funds, while also prohibiting government control over these organizations and protecting private and religious schools from discrimination in the program. It establishes a $10 billion annual cap on the total tax credits available.
Maddy summaryThis bill expands foreign investment review to cover U.S. agriculture by requiring transactions involving foreign control of agricultural businesses to undergo scrutiny by the Committee on Foreign Investment (CFIUS). It classifies agricultural supply chains as both critical infrastructure and critical technologies, directly affecting foreign entities seeking to acquire or influence U.S. farms, food production, and supply chains. The bill mandates annual reports from the Secretary of Agriculture and the Government Accountability Office on foreign investments in agriculture, including risks to food security and intellectual property. These provisions aim to mitigate potential threats to U.S. food supply chains from foreign adversaries through enhanced oversight.
Maddy summaryThis bill requires healthcare providers to give the same medical care to infants born alive during abortions as they would to any newborn, and to immediately admit such infants to a hospital. It mandates reporting of non-compliance to law enforcement and imposes penalties including up to 5 years in prison for violations. Women who undergo abortions can file civil lawsuits seeking money damages for injuries, three times the abortion cost, and punitive damages if care standards are not met. The bill also clarifies that abortion includes intentionally killing an unborn child or terminating pregnancy without specific exceptions (e.g., after viability to preserve life or removing a dead fetus).
Maddy summaryHR 23, the Family and Small Business Taxpayer Protection Act, rescinds unobligated funds previously allocated to the Internal Revenue Service (IRS) under the Inflation Reduction Act of 2022. Specifically, it cancels unused balances from certain IRS funding provisions (sections 10301(1)(A)(ii), (iii), (B), (2), (3), (4), and (5)) of the Inflation Reduction Act. This bill does not change tax laws or directly affect taxpayers; it only redirects unspent IRS budget authority. The provision applies solely to funds that were not obligated by the IRS as of the bill’s enactment date.
Maddy summaryHR 469, the Asylum Abuse Reduction Act, changes how asylum seekers enter the U.S. by requiring most people crossing the southern border from Mexico or Canada without a visa to schedule asylum interviews at U.S. embassies in those countries instead of entering the U.S. directly. It also makes asylum ineligible for individuals who traveled through other countries (except Mexico/Canada) to reach the U.S., with limited exceptions for those denied protection in transit countries, trafficking victims, or transit through non-refugee-convention countries. The bill removes restrictions from the Flores Agreement, allowing indefinite detention of immigrants subject to removal, and creates criminal warrants for immigration violations. These changes primarily affect asylum seekers entering via land borders from Mexico or Canada who transit through other nations.
This resolution declares that every state within the United States has the sovereign right to exclude any person who does not have the right to be there. It also declares that the states along the southern border (1) are being invaded by terrorists, narco-terrorist cartels, and criminal actors; and (2) have the sovereign and unilateral authority to defend themselves against such an invasion.